-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Estrella Immunopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2021 to Q3 2023.
- Estrella Immunopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2023 was $20M.
- Estrella Immunopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$35.6M, a 177% decline from 2021.